Literature DB >> 20363914

Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney.

Takahiro Nakayama1, Waichi Sato, Ashio Yoshimura, Li Zhang, Tomoki Kosugi, Martha Campbell-Thompson, Hideto Kojima, Byron P Croker, Takahiko Nakagawa.   

Abstract

Endothelial dysfunction is critical in the decline of renal function with. By using endothelial nitric oxide synthase knockout (eNOSKO) mice, we tested the hypothesis that a lack of endothelial nitric oxide synthase accelerates renal injury in the aging kidney. In contrast to control mice and young eNOSKO mice, aging eNOSKO mice showed greater renal injury and in particular developed a thrombotic microangiopathy, with mesangiolysis, endothelial swelling, endothelial cell loss, double-contour appearance of glomerular basement membrane (GBM), and thrombus formation. Thrombi, which were composed of fibrin, platelets, and von Willebrand factor (vWF), were identified predominantly in glomerular capillaries and rarely in arterioles, but not in larger vessels. In the tubulointerstitium, tubular degeneration and macrophage infiltration were also prominent in aging eNOSKO mice. Intraluminal vWF deposition was accompanied with thrombus formation, whereas mesangial deposition of vWF was associated with mesangial matrix expansion. Furthermore, the mesangial vWF deposition was detectable in young eNOSKO mice in which severe glomerular injury had not yet developed. Finally, a higher level of serum P-selectin in eNOSKO mice was consistent with the vWF behavior and suggested exocytosis of the Weibel-Palade body by the endothelium. In conclusion, a lack of endothelial nitric oxide synthase resulted in the development of glomerular thrombotic microangiopathy. A lack of nitric oxide likely contributed to the release of vWF, leading to thrombus formation in this model.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20363914      PMCID: PMC2861085          DOI: 10.2353/ajpath.2010.090316

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Evaluation of a thick and thin section method for estimation of podocyte number, glomerular volume, and glomerular volume per podocyte in rat kidney with Wilms' tumor-1 protein used as a podocyte nuclear marker.

Authors:  Silja K Sanden; Jocelyn E Wiggins; Meera Goyal; Lisa K Riggs; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

2.  Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.

Authors:  P Heeringa; H van Goor; Y Itoh-Lindstrom; N Maeda; R J Falk; K J Assmann; C G Kallenberg; J C Jennette
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

3.  Inducible nitric oxide synthase inhibition of weibel-palade body release in cardiac transplant rejection.

Authors:  Z Qian; R Gelzer-Bell; S X Yang Sx; W Cao; T Ohnishi; B A Wasowska; R H Hruban; E R Rodriguez; W M Baldwin; C J Lowenstein
Journal:  Circulation       Date:  2001-11-06       Impact factor: 29.690

4.  Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.

Authors:  D H Kang; S Anderson; Y G Kim; M Mazzalli; S Suga ; J A Jefferson; K L Gordon; T T Oyama; J Hughes; C Hugo; D Kerjaschki; G F Schreiner; R J Johnson
Journal:  Am J Kidney Dis       Date:  2001-03       Impact factor: 8.860

Review 5.  Cyclic GMP signaling in podocytes.

Authors:  Barbara Lewko; Jan Stepinski
Journal:  Microsc Res Tech       Date:  2002-05-15       Impact factor: 2.769

Review 6.  Thrombotic microangiopathy, hemolytic uremic syndrome, and thrombotic thrombocytopenic purpura.

Authors:  P Ruggenenti; M Noris; G Remuzzi
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

7.  Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases.

Authors:  Vera Eremina; Manish Sood; Jody Haigh; András Nagy; Ginette Lajoie; Napoleone Ferrara; Hans-Peter Gerber; Yamato Kikkawa; Jeffrey H Miner; Susan E Quaggin
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

8.  Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor.

Authors:  Kenji Matsushita; Craig N Morrell; Beatrice Cambien; Shui Xiang Yang; Munekazu Yamakuchi; Clare Bao; Makoto R Hara; Richard A Quick; Wangsen Cao; Brian O'Rourke; John M Lowenstein; Jonathan Pevsner; Denisa D Wagner; Charles J Lowenstein
Journal:  Cell       Date:  2003-10-17       Impact factor: 41.582

9.  Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse.

Authors:  Takahiro Nakayama; Waichi Sato; Tomoki Kosugi; Li Zhang; Martha Campbell-Thompson; Ashio Yoshimura; Byron P Croker; Richard J Johnson; Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2008-11-26

10.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

Authors:  Jing-fei Dong; Joel L Moake; Leticia Nolasco; Aubrey Bernardo; Wendy Arceneaux; Corie N Shrimpton; Alicia J Schade; Larry V McIntire; Kazuo Fujikawa; José A López
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

View more
  19 in total

Review 1.  Endothelial dysfunction as a potential contributor in diabetic nephropathy.

Authors:  Takahiko Nakagawa; Katsuyuki Tanabe; Byron P Croker; Richard J Johnson; Maria B Grant; Tomoki Kosugi; Qiuhong Li
Journal:  Nat Rev Nephrol       Date:  2010-11-02       Impact factor: 28.314

2.  Mitochondria Protection after Acute Ischemia Prevents Prolonged Upregulation of IL-1β and IL-18 and Arrests CKD.

Authors:  Hazel H Szeto; Shaoyi Liu; Yi Soong; Surya V Seshan; Leona Cohen-Gould; Viacheslav Manichev; Leonard C Feldman; Torgny Gustafsson
Journal:  J Am Soc Nephrol       Date:  2016-11-23       Impact factor: 10.121

3.  Selective stimulation of VEGFR2 accelerates progressive renal disease.

Authors:  Waichi Sato; Katsuyuki Tanabe; Tomoki Kosugi; Kelly Hudkins; Miguel A Lanaspa; Li Zhang; Martha Campbell-Thompson; Qiuhong Li; David A Long; Charles E Alpers; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

Review 4.  Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression.

Authors:  Sunil Rangarajan; Jillian R Richter; Robert P Richter; Shyam K Bandari; Kaushlendra Tripathi; Israel Vlodavsky; Ralph D Sanderson
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

5.  Mesenchymal stem cell marker Stro-1 is a 75 kd endothelial antigen.

Authors:  Hongxiu Ning; Guiting Lin; Tom F Lue; Ching-Shwun Lin
Journal:  Biochem Biophys Res Commun       Date:  2011-08-27       Impact factor: 3.575

6.  The role of endothelial cell injury in thrombotic microangiopathy.

Authors:  Ryan J Goldberg; Takahiko Nakagawa; Richard J Johnson; Joshua M Thurman
Journal:  Am J Kidney Dis       Date:  2010-09-16       Impact factor: 8.860

7.  Serum uric acid level and endothelial dysfunction in patients with nondiabetic chronic kidney disease.

Authors:  Mehmet Kanbay; Mahmut Ilker Yilmaz; Alper Sonmez; Faruk Turgut; Mutlu Saglam; Erdinc Cakir; Mujdat Yenicesu; Adrian Covic; Diana Jalal; Richard J Johnson
Journal:  Am J Nephrol       Date:  2011-03-08       Impact factor: 3.754

8.  Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors.

Authors:  Emily S Robinson; Eliyahu V Khankin; Toni K Choueiri; Mallika S Dhawan; Miranda J Rogers; S Ananth Karumanchi; Benjamin D Humphreys
Journal:  Hypertension       Date:  2010-10-18       Impact factor: 10.190

9.  Vascular endothelial cell injury partly induced by mesenteric lymph in heat stroke.

Authors:  HuaSheng Tong; Peng Wan; XingQin Zhang; PengKai Duan; YouQing Tang; Yi Chen; LiQun Tang; Lei Su
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

10.  Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse.

Authors:  Katsuyuki Tanabe; Miguel A Lanaspa; Wataru Kitagawa; Christopher J Rivard; Makoto Miyazaki; Jelena Klawitter; George F Schreiner; Moin A Saleem; Peter W Mathieson; Hirofumi Makino; Richard J Johnson; Takahiko Nakagawa
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.